ArticleFrontiers in oncology2025

Nontargeted metabolomics uncovering metabolite signatures in glioblastoma: a preliminary study on candidate biomarker discovery for IDH subtyping and survival prediction.

Peng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.